The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009
Open accessAbstract
primary brain and CNS tumors in the United States.This report represents a dramatic increase in population coverage (approximately 97% from the initial CBTRUS Reports).The central cancer registries receive populationbased, standardized data from all healthcare data sources primarily through certified tumor registrars.Along with the UDS, there are quality control checks and a system for rating each central registry to further insure that these data are reported as accurately and completely as possible.These individuals and organizations provide the high quality data that are the foundation of the CBTRUS statistical reports and scientific activities.This statistical report continues the past efforts that CBTRUS has made to provide population-based incidence rates for all primary brain and CNS tumors by histology, age, gender, race, and Hispanic ethnicity.As in previous reports, these data have been organized by clinically relevant histological groupings that are useful for surveillance.The information is important for allocation and planning of specialty health -care services, in the planning of disease prevention and control programs, and in research activities.These data may lead to clues that will stimulate research into the causes of this terrible disease.In 2012, the CBTRUS staff in collaboration with three neuropathologists, Drs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, other studies have reported elevated HIF-1α expression in highly aggressive and necrotic tumors, revealed associations of HIF-1α with MYCN-amplified NB, a subtype associated with poor prognosis, and reported causal roles of HIF-1α in etoposide resistance [40–42].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [42]
Citations
Cites
The New WHO Classification of Brain Tumours
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00752.x · Cited by 1,587
International Classification of Childhood Cancer, third edition
Steliarova‐Foucher, E., Stiller, C., Lacour, B., & Kaatsch, P. (2005) · Cancer · doi:10.1002/cncr.20910 · Cited by 1,552
Efficient interval estimation for age-adjusted cancer rates
Tiwari, R. C., Clegg, L. X., & Zou, Z. (2006) · Statistical Methods in Medical Research · doi:10.1177/0962280206070621 · Cited by 566
Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1537 · Cited by 278
Factors associated with survival in patients with meningioma
McCarthy, B. J., Davis, F. G., Freels, S., Surawicz, T. S., Damek, D. M., Grutsch, J., Menck, H. R., & Laws, E. R. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.88.5.0831 · Cited by 232
Howlader, N., Ries, L. A. G., Stinchcomb, D. G., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn517 · Cited by 75
Research works printed but not linked: 1
- 2002, Neuro-Oncology, 4:1, 34
Cited by
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
“Although reported median survival for patients with GBM ranges from 12–18 months, a subset of individuals will survive for more than 3 years (Dolecek et al., 2012; Dunn et al., 2012).”
BackgroundVariation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
Cancer Research Communications
(2021) · doi:10.1158/1078-0432 · Cited by 1,532
Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Metadata
- Authors
- Dolecek, T. A., Propp, J. M., Stroup, N. E., & Kruchko, C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10-24
- Volume
- 14
- Issue
- suppl 5
- Pages
- v1-v49
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- PMC
- PMC3480240
- OpenAlex
- W4242403727
- Cited by
- 1,710
- References
- 6
- Citations by year
- 2026: 24 · 2025: 44 · 2024: 50 · 2023: 87 · 2022: 79 · 2021: 159 · 2020: 105 · 2019: 115 · 2018: 157 · 2017: 182 · 2016: 148 · 2015: 187 · 2014: 215 · 2013: 133 · 2012: 16
- FWCI
- 83.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neuro-Oncology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
- Keywords
- primary brain tumors, central nervous system tumors, incidence rates, histological subtypes, cancer registry, United States, age and sex differences, racial and ethnic differences, Hispanic origin, tumor surveillance
- MeSH terms
- Brain Neoplasms, Data Collection, Humans, Mortality, Registries, Time Factors, United States, Confounding Factors, Epidemiologic, Central Nervous System Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. https://app.cochat.ai/papers/10.1093/neuonc/nos218
- The paper
- Dolecek, T. A., Propp, J. M., Stroup, N. E., & Kruchko, C. (2012). CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro-Oncology. https://doi.org/10.1093/neuonc/nos218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.